SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: Haim R. Branisteanu who wrote (150157)2/28/2020 11:45:25 AM
From: Pogeu Mahone  Read Replies (1) | Respond to of 219938
 
The U.S. Food and Drug Administration said it has been alerted to the first manufacturing shortage of an unnamed drug due to the deadly novel coronavirus outbreak that began in China and has now reached the U.S..

FDA Commissioner Stephen Hahn said the agency has been "closely monitoring" the medical product supply chain "with the expectation" that the outbreak of the novel coronavirus would "likely" have an impact.

"A manufacturer has alerted us to a shortage of a human drug that was recently added to the drug shortages list," Hahn said in a statement Thursday night. "The manufacturer just notified us that this shortage is related to a site affected by coronavirus. The shortage is due to an issue with manufacturing of an active pharmaceutical ingredient used in the drug."

MORE: Coronavirus could lead to drug shortages in US

"It is important to note that there are other alternatives that can be used by patients," he added. "We are working with the manufacturer as well as other manufacturers to mitigate the shortage. We will do everything possible to mitigate the shortage."

Hahn said the issue continues to be "an evolving and very dynamic" one.





People line up at a pharmacy to purchase N95 face masks in advance of the potential coronavirus outbreak in the Manhattan borough of New York City, New York, Feb. 27, 2020.
People line up at a pharmacy to purchase N95 face masks in advance of the potential coronavirus outbreak in the Manhattan borough of New York City, New York, Feb. 27, 2020.Carlo Allegri/Reuters

abcnews.go.com